American Shared Hospital Services (NYSEAMERICAN:AMS) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com began coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock.

American Shared Hospital Services Stock Up 3.1 %

Shares of NYSEAMERICAN:AMS opened at $3.30 on Monday. The company has a market cap of $20.89 million, a P/E ratio of 41.26 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.98 and a current ratio of 1.98. American Shared Hospital Services has a 12-month low of $2.16 and a 12-month high of $3.69.

American Shared Hospital Services (NYSEAMERICAN:AMS) last announced its quarterly earnings results on Tuesday, May 14th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.01). American Shared Hospital Services had a net margin of 2.50% and a return on equity of 4.29%. The company had revenue of $5.22 million during the quarter, compared to analysts’ expectations of $5.01 million. Analysts forecast that American Shared Hospital Services will post 0.29 EPS for the current fiscal year.

Institutional Trading of American Shared Hospital Services

An institutional investor recently bought a new position in American Shared Hospital Services stock. Empowered Funds LLC acquired a new position in shares of American Shared Hospital Services (NYSEAMERICAN:AMS) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned about 0.17% of American Shared Hospital Services at the end of the most recent reporting period. Institutional investors and hedge funds own 23.16% of the company’s stock.

American Shared Hospital Services Company Profile

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.